X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Guest Post: Pride started with protest: Combatting the dual pandemics of COVID-19 and racism this Pride Month

By Guest Contributor  |    June 30, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

How biopharmaceutical researchers are ensuring COVID-19 vaccines will be safe and effective­

By Richard Moscicki, M.D.  |    June 29, 2020
As the world continues to feel the impact of COVID-19, the biopharmaceutical industry is working around the clock to identify and develop safe and effective vaccines to prevent infection, while...   Read More

Guest Post: Takeda seeks ‘new normal’ for cancer research during the COVID-19 pandemic

By Guest Contributor  |    June 24, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

In combating COVID-19, science is how we get back to normal

By Lori Reilly  |    June 24, 2020
America’s biopharmaceutical companies are working around the clock to combat a common enemy: COVID-19. As the fight to research and develop innovative treatments and vaccines advances, I’m pleased...   Read More

Guest post: A post-pandemic crisis: The mental toll on America

By Guest Contributor  |    June 16, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Stakeholders raise concerns with proposed drastic changes to the pharmaceutical supply chain

By Nicole Longo  |    June 11, 2020
As we work to combat the current global pandemic, it is especially critical to maintain the stability of our global manufacturing supply chain. Unfortunately, recent policy proposals that would...   Read More

Guest Post: From lab to jab: Vaccine development to prevent COVID-19

By Guest Contributor  |    June 11, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

PhRMA awards $100,000 to fund projects that address health inequalities

By Lori Reilly  |    June 10, 2020
As part of PhRMA’s continuing work to address health inequalities, we are awarding $100,000 total in grants to fund four projects that will help improve health outcomes by addressing inequity in...   Read More

The latest: What they are saying: Intellectual property protections critical as we work to defeat COVID-19

By Tom Wilbur  |    June 5, 2020
The U.S. biopharmaceutical industry depends on reliable intellectual property (IP) protections to promote the development of new treatments and cures for patients. Strong IP protections are...   Read More

America’s global leadership in biopharmaceutical manufacturing

By Nicole Longo  |    June 4, 2020
Unfortunately, there are a lot of assertions floating around that tell a misleading story about pharmaceutical manufacturing, diminishing America’s leadership and suggesting our reliance on other...   Read More

What scientific experts are saying about vaccine safety

By Andrew Powaleny  |    June 4, 2020
Vaccines have played a critical role in reducing the spread of, and in some cases, eliminating the threat of many devastating infectious diseases. They are often cited as second only to clean...   Read More

ICYMI: Pharmacy benefit managers increasingly exclude medicines from formularies, restricting patient access

By Gabby Migliara  |    June 1, 2020
The two largest pharmacy benefit managers (PBMs), CVS Caremark and Express Scripts, have once again increased the number of medicines on their standard formulary exclusion lists. Medicines...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

Subscribe to Email Updates